These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Study of glutathione and glutathione related enzymes in acetaminophen-poisoned mice. Prevention by anethole trithione pretreatment. Warnet JM; Christen MO; Thevenin M; Biard D; Jacqueson A; Claude JR Arch Toxicol Suppl; 1989; 13():322-5. PubMed ID: 2774955 [No Abstract] [Full Text] [Related]
8. Dithiolthione-induced alterations in hepatic glutathione and related enzymes in male mice. Davies MH; Blacker AM; Schnell RC Biochem Pharmacol; 1987 Feb; 36(4):568-70. PubMed ID: 3827943 [No Abstract] [Full Text] [Related]
9. Enhancement of salivary secretion and neuropeptide (substance P, alpha-calcitonin gene-related peptide) levels in saliva by chronic anethole trithione treatment. Nagano T; Takeyama M J Pharm Pharmacol; 2001 Dec; 53(12):1697-702. PubMed ID: 11804400 [TBL] [Abstract][Full Text] [Related]
10. Studies on the whole-body distribution of 14C-trithioparamethoxyphenylpropene in mice. Isacsson G; Singer P Scand J Dent Res; 1985 Jun; 93(3):249-52. PubMed ID: 3860910 [TBL] [Abstract][Full Text] [Related]
11. [Interaction studies using catapresan depot perlongette and a sialogenous drug]. Langbehn AF; Beurich HW; Kiebbel E; Wolk M Med Welt; 1981 Jan; 32(5):171-2. PubMed ID: 7207153 [No Abstract] [Full Text] [Related]
12. [Clinical experience in the treatment of non-iatrogenic xerostomia and xerophthalmia with trithioparamethoxyphenylpropene]. Bianucci G; Campana G; Maddali Bongi S; Castagnoli A; Passigli G Clin Ter; 1984 Jun; 109(5):417-27. PubMed ID: 6236932 [No Abstract] [Full Text] [Related]
13. [Hepatic tolerance of trithioparamethoxyphenylpropene in cirrhosis]. Hecht Y Med Chir Dig; 1979; 8(2):175-8. PubMed ID: 379468 [No Abstract] [Full Text] [Related]
14. A new potent inhibitor of lipid peroxidation in vitro and in vivo, the hepatoprotective drug anisyldithiolthione. Mansuy D; Sassi A; Dansette PM; Plat M Biochem Biophys Res Commun; 1986 Mar; 135(3):1015-21. PubMed ID: 3964266 [TBL] [Abstract][Full Text] [Related]
15. [Clinical picture, diagnosis and therapy of xerostomia--attempt of a survey under pathophysiological aspects (author's transl)]. Chilla R HNO; 1982 Jun; 30(6):201-7. PubMed ID: 7107333 [TBL] [Abstract][Full Text] [Related]
16. [Clinical study with a sialagogue drug (sulfarlem S 25 = TTPT) in the treatment of xerostomia (author's transl)]. Häusler R; Ritschard J Schweiz Rundsch Med Prax; 1979 Aug; 68(33):1063-8. PubMed ID: 471936 [No Abstract] [Full Text] [Related]
17. Action of carbamylcholine on the striated ducts glycogen in mammalian salivary glands. Fava-De-Moraes F; Giuffrida R; Junqueira LC Acta Histochem; 1967; 27(1):1-8. PubMed ID: 4968547 [No Abstract] [Full Text] [Related]
18. [Changes in the histophysiology of the salivary glands after administration of neuropsychotropics]. Lopez Arranz JS; Hinojal Fonseca DR Rev Esp Estomatol; 1978; 26(2):93-8. PubMed ID: 283464 [No Abstract] [Full Text] [Related]
19. [Anethole dithiolethione: an antioxidant agent against tenotoxicity induced by fluoroquinolones]. Pouzaud F; Christen MO; Warnet JM; Rat P Pathol Biol (Paris); 2004 Jul; 52(6):308-13. PubMed ID: 15261372 [TBL] [Abstract][Full Text] [Related]
20. [The clinical therapic efficiency of anethol trithione on dry eye]. Wang H; Liu ZG; Peng J; Lin H; Zhong JX; Hu JY Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):492-7. PubMed ID: 19957670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]